MCEWEN INC (MUX) Fundamental Analysis & Valuation

NYSE:MUX • US58039P3055

Current stock price

23.04 USD
+0.69 (+3.09%)
At close:
23.04 USD
0 (0%)
After Hours:

This MUX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. MUX Profitability Analysis

1.1 Basic Checks

  • MUX had positive earnings in the past year.
  • In the past year MUX had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: MUX reported negative net income in multiple years.
  • In multiple years MUX reported negative operating cash flow during the last 5 years.
MUX Yearly Net Income VS EBIT VS OCF VS FCFMUX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

1.2 Ratios

  • MUX has a better Return On Assets (4.20%) than 70.44% of its industry peers.
  • MUX's Return On Equity of 6.30% is fine compared to the rest of the industry. MUX outperforms 67.92% of its industry peers.
Industry RankSector Rank
ROA 4.2%
ROE 6.3%
ROIC N/A
ROA(3y)2.01%
ROA(5y)-4.02%
ROE(3y)2.83%
ROE(5y)-6.35%
ROIC(3y)N/A
ROIC(5y)N/A
MUX Yearly ROA, ROE, ROICMUX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30 -40

1.3 Margins

  • MUX has a better Profit Margin (17.43%) than 78.62% of its industry peers.
  • MUX has a Gross Margin of 24.08%. This is comparable to the rest of the industry: MUX outperforms 59.75% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 17.43%
GM 24.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MUX Yearly Profit, Operating, Gross MarginsMUX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. MUX Health Analysis

2.1 Basic Checks

  • MUX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MUX has been increased compared to 1 year ago.
  • MUX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, MUX has a worse debt to assets ratio.
MUX Yearly Shares OutstandingMUX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
MUX Yearly Total Debt VS Total AssetsMUX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • MUX has an Altman-Z score of 1.08. This is a bad value and indicates that MUX is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.08, MUX is not doing good in the industry: 80.50% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.23 indicates that MUX is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.23, MUX is in line with its industry, outperforming 43.40% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACC12.02%
MUX Yearly LT Debt VS Equity VS FCFMUX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • MUX has a Current Ratio of 1.69. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.69, MUX is doing worse than 65.41% of the companies in the same industry.
  • MUX has a Quick Ratio of 1.27. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.
  • MUX has a worse Quick ratio (1.27) than 60.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.27
MUX Yearly Current Assets VS Current LiabilitesMUX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. MUX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 201.61% over the past year.
  • Looking at the last year, MUX shows a quite strong growth in Revenue. The Revenue has grown by 13.23% in the last year.
  • MUX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.52% yearly.
EPS 1Y (TTM)201.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%359.26%
Revenue 1Y (TTM)13.23%
Revenue growth 3Y21.41%
Revenue growth 5Y13.52%
Sales Q2Q%92.77%

3.2 Future

  • MUX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.92% yearly.
  • Based on estimates for the next years, MUX will show a very strong growth in Revenue. The Revenue will grow by 22.11% on average per year.
EPS Next Y111.09%
EPS Next 2Y94.79%
EPS Next 3Y48.92%
EPS Next 5YN/A
Revenue Next Year51.53%
Revenue Next 2Y40.94%
Revenue Next 3Y22.11%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MUX Yearly Revenue VS EstimatesMUX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
MUX Yearly EPS VS EstimatesMUX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2

More info and screens

Find the best growth stocksShow best growing peers

4

4. MUX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 36.57, which means the current valuation is very expensive for MUX.
  • Based on the Price/Earnings ratio, MUX is valued a bit cheaper than 62.26% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.78. MUX is valued slightly more expensive when compared to this.
  • MUX is valuated rather expensively with a Price/Forward Earnings ratio of 17.33.
  • Based on the Price/Forward Earnings ratio, MUX is valued a bit cheaper than the industry average as 64.15% of the companies are valued more expensively.
  • MUX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 36.57
Fwd PE 17.33
MUX Price Earnings VS Forward Price EarningsMUX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as MUX.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 93.99
MUX Per share dataMUX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • MUX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MUX's earnings are expected to grow with 48.92% in the coming years.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y94.79%
EPS Next 3Y48.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MUX Dividend Analysis

5.1 Amount

  • MUX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MUX Fundamentals: All Metrics, Ratios and Statistics

MCEWEN INC

NYSE:MUX (4/10/2026, 8:04:00 PM)

After market: 23.04 0 (0%)

23.04

+0.69 (+3.09%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-12
Earnings (Next)05-05
Inst Owners50.22%
Inst Owner Change0%
Ins Owners0.55%
Ins Owner Change0.04%
Market Cap1.37B
Revenue(TTM)197.55M
Net Income(TTM)34.43M
Analysts80
Price Target32.33 (40.32%)
Short Float %18.38%
Short Ratio7.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)50.92%
Min EPS beat(2)-106.19%
Max EPS beat(2)208.03%
EPS beat(4)2
Avg EPS beat(4)148.15%
Min EPS beat(4)-106.19%
Max EPS beat(4)494.06%
EPS beat(8)4
Avg EPS beat(8)54.39%
EPS beat(12)6
Avg EPS beat(12)8.34%
EPS beat(16)7
Avg EPS beat(16)-24.68%
Revenue beat(2)1
Avg Revenue beat(2)-6.91%
Min Revenue beat(2)-22.09%
Max Revenue beat(2)8.26%
Revenue beat(4)1
Avg Revenue beat(4)-7.27%
Min Revenue beat(4)-22.09%
Max Revenue beat(4)8.26%
Revenue beat(8)5
Avg Revenue beat(8)-1.24%
Revenue beat(12)7
Avg Revenue beat(12)-0.95%
Revenue beat(16)7
Avg Revenue beat(16)-5.06%
PT rev (1m)16.12%
PT rev (3m)40.27%
EPS NQ rev (1m)11.54%
EPS NQ rev (3m)38.1%
EPS NY rev (1m)-17.02%
EPS NY rev (3m)-7.6%
Revenue NQ rev (1m)13.22%
Revenue NQ rev (3m)13.22%
Revenue NY rev (1m)4.5%
Revenue NY rev (3m)5.21%
Valuation
Industry RankSector Rank
PE 36.57
Fwd PE 17.33
P/S 6.93
P/FCF N/A
P/OCF 199.52
P/B 2.51
P/tB 2.51
EV/EBITDA 93.99
EPS(TTM)0.63
EY2.73%
EPS(NY)1.33
Fwd EY5.77%
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)0.12
OCFY0.5%
SpS3.32
BVpS9.19
TBVpS9.19
PEG (NY)0.33
PEG (5Y)N/A
Graham Number11.41
Profitability
Industry RankSector Rank
ROA 4.2%
ROE 6.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 17.43%
GM 24.08%
FCFM N/A
ROA(3y)2.01%
ROA(5y)-4.02%
ROE(3y)2.83%
ROE(5y)-6.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 8.45
Cap/Depr 168.02%
Cap/Sales 23.69%
Interest Coverage N/A
Cash Conversion 46%
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.27
Altman-Z 1.08
F-Score6
WACC12.02%
ROIC/WACCN/A
Cap/Depr(3y)168.71%
Cap/Depr(5y)153.31%
Cap/Sales(3y)28.21%
Cap/Sales(5y)26.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)201.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%359.26%
EPS Next Y111.09%
EPS Next 2Y94.79%
EPS Next 3Y48.92%
EPS Next 5YN/A
Revenue 1Y (TTM)13.23%
Revenue growth 3Y21.41%
Revenue growth 5Y13.52%
Sales Q2Q%92.77%
Revenue Next Year51.53%
Revenue Next 2Y40.94%
Revenue Next 3Y22.11%
Revenue Next 5YN/A
EBIT growth 1Y-2.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6197.24%
EBIT Next 3Y294.5%
EBIT Next 5YN/A
FCF growth 1Y-192.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.69%
OCF growth 3YN/A
OCF growth 5YN/A

MCEWEN INC / MUX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MCEWEN INC (MUX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to MUX.


What is the valuation status of MCEWEN INC (MUX) stock?

ChartMill assigns a valuation rating of 4 / 10 to MCEWEN INC (MUX). This can be considered as Fairly Valued.


How profitable is MCEWEN INC (MUX) stock?

MCEWEN INC (MUX) has a profitability rating of 3 / 10.


Can you provide the financial health for MUX stock?

The financial health rating of MCEWEN INC (MUX) is 2 / 10.


Can you provide the expected EPS growth for MUX stock?

The Earnings per Share (EPS) of MCEWEN INC (MUX) is expected to grow by 111.09% in the next year.